source
- STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and morePresident Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.STAT · 7d ago↗ source
- Crystalys gets $130M to take Sobi-rivaling gout drug to marketA San Diego biotech has raised an additional $130 million to get a gout drug that's already approved in Japan and China onto the US and European markets. Crystalys Therapeutics reeled in the Series…Endpoints · 8d ago↗ source
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsWhat Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health news